Protein Carbonylation in Neurodegenerative and Demyelinating CNS Diseases

Carbonylation is the most common protein modification that takes place as consequence of severe oxidative stress. Carbonyl (C = O) groups are introduced into proteins by direct metal-catalyzed oxidation of certain amino acids or indirectly by reaction wit

  • PDF / 319,909 Bytes
  • 20 Pages / 467.716 x 710.929 pts Page_size
  • 68 Downloads / 233 Views

DOWNLOAD

REPORT


Protein Carbonylation in Neurodegenerative and Demyelinating CNS Diseases

O. A. Bizzozero

1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 544

2 2.1 2.2 2.3 2.4

Chemical and Biochemical Aspects of Protein Carbonylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 545 Chemistry of Protein Carbonylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 545 Measurement of Protein Carbonyls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 546 Experimental Models for Induction of Protein Carbonyls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 548 Removal of Protein Carbonyls from Oxidized Tissues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 549

3

Functional Consequences of Protein Carbonylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550

4 4.1 4.2 4.3 4.4 4.5 4.6 4.7

CNS Disorders Associated with Carbonylated Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 551 Alzheimer’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 551 Parkinson’s Disease (PD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 552 Amyotrophic Lateral Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 553 Huntington’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 553 Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 553 Other CNS Conditions Associated with Carbonyl Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 555 Protein Carbonylation Profiles in Different CNS Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 555

5

Pharmacological Approaches to Prevent Protein Carbonyl Formation . . . . . . . . . . . . . . . . . . . . . . . . . 555

6

Concluding Remarks and Perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 556

#

2009 Springer ScienceþBusiness Media, LLC.

544

23

Protein carbonylation in neurodegenerative and demyelinating CNS diseases

Abstract: Carbonylation is the most common protein modification that takes place as consequence of severe